Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Fredrik Waneck"'
Autor:
Julian Frederic Hotz, Klaus Kaczirek, Stefan Stremitzer, Fredrik Waneck, Herbert Auer, Thomas Perkmann, Manuel Kussmann, Philipp Karl Bauer, Rui-Yang Chen, Richard Kriz, Heinz Burgmann, Michael Ramharter, Heimo Lagler
Publikováno v:
Pathogens, Vol 11, Iss 2, p 261 (2022)
Echinococcosis is a neglected zoonotic disease and a worldwide public health problem caused by infection with the larval stages of taeniid cestodes of the genus Echinococcus. In vitro studies have demonstrated a protoscolecidal effect of eosinophilic
Externí odkaz:
https://doaj.org/article/6c1c14fbd272494a9389cf4fb2750b0c
Autor:
Christoph C Zielinski, Markus Kieler, Matthias Unseld, Daniela Bianconi, Fredrik Waneck, Robert Mader, Fritz Wrba, Thorsten Fuereder, Philipp Staber, Walter Berger, Maria Sibilia, Stephan Polterauer, Leonhard Müllauer, Gerald W Prager
Publikováno v:
ESMO Open, Vol 4, Iss 4 (2019)
Background High-throughput genomic profiling of tumour specimens facilitates the identification of individual actionable mutations which could be used for individualised targeted therapy. This approach is becoming increasingly more common in the clin
Externí odkaz:
https://doaj.org/article/a302d32bee064beda7f655065565cb61
Autor:
Felix Lötsch, Christine M Budke, Herbert Auer, Klaus Kaczirek, Fredrik Waneck, Heimo Lagler, Michael Ramharter
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 1, p e0007110 (2019)
BACKGROUND:Cystic echinococcosis (CE) is a globally occurring zoonosis, whereas alveolar echinococcosis (AE) is endemic only in certain parts of the Northern Hemisphere. The socioeconomic impact of human echinococcosis has been shown to be considerab
Externí odkaz:
https://doaj.org/article/4f443f8b3c094656bb83bc56bdf951d4
Autor:
Felix Lötsch, Fredrik Waneck, Herbert Auer, Klaus Kaczirek, Georgios Karanikas, Michael Ramharter
Publikováno v:
International Journal of Infectious Diseases, Vol 64, Iss , Pp 67-68 (2017)
Externí odkaz:
https://doaj.org/article/fe0161398ced4863857bed40ed415fdf
Autor:
Henning Wege, Bernhard Scheiner, Fredrik Waneck, Philipp Schwabl, Fabian Finkelmeier, Matthias Pinter, F. Hucke, Jörg Trojan, Thomas Reiberger, Arndt Vogel, Sandra Koch, Kornelius Schulze, Michael Trauner, Markus Peck-Radosavljevic, Oliver Waidmann, Wolfgang Sieghart, Jan B. Hinrichs, Arndt Weinmann, Christian Müller, Martha M. Kirstein, Johann von Felden
Publikováno v:
Alimentary Pharmacology & Therapeutics. 49:1323-1333
Programmed cell death protein-1-targeted immunotherapy has shown promising results in phase II studies of hepatocellular carcinoma.To evaluate safety and efficacy of nivolumab and pembrolizumab in an international, multicentre, real-world cohort of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::990d742a56daa4f98b21ddc9f3cd2465
https://doi.org/10.1111/apt.15245
https://doi.org/10.1111/apt.15245
Autor:
Michael Ramharter, Felix Lötsch, Mirjam Groger, Wolfgang Wadsak, Ivo Rausch, Herbert Auer, Fredrik Waneck, Georgios Karanikas, Klaus Kaczirek, Heimo Lagler, Marcus Hacker
Publikováno v:
Tropical Medicine & International Health. 24:663-670
[Here, we describe the initial clinical experience with comparative PET/CT and PET/MR imaging in four human AE patients at an Austrian reference centre.PET/MR imaging showed comparable diagnostic capacity for liver lesions attributable to E. multiloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c5e38065ff4f578e94df867c26e0b4
https://doi.org/10.1111/tmi.13228
https://doi.org/10.1111/tmi.13228
Autor:
Robert M. Mader, Markus Kieler, Matthias Unseld, Thorsten Fuereder, Gerald W. Prager, Fredrik Waneck, Alexander Reinthaller, Markus Raderer, Heinz Kölbl, Leonhard Müllauer, Daniela Bianconi, Lukas Baumann, Maria Sibilia, Walter Berger, Christoph C. Zielinski, Phillip Staber, Ulrich Jäger, Mir Alireza Hoda, Christoph Grimm, Fritz Wrba
Publikováno v:
Oncotarget
Scopus-Elsevier
Scopus-Elsevier
// Gerald W. Prager 1, 8 , Matthias Unseld 1, 8 , Fredrik Waneck 3, 8 , Robert Mader 1, 8 , Fritz Wrba 2, 8 , Markus Raderer 1, 8 , Thorsten Fuereder 1, 8 , Phillip Staber 4, 8 , Ulrich Jager 4, 8 , Markus Kieler 1, 8 , Daniela Bianconi 1, 8 , Mir Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74fbd2bd080b8c251e34600377abe5c3
http://europepmc.org/articles/PMC6398177
http://europepmc.org/articles/PMC6398177
Autor:
Richard Nolz, Christian Loewe, Christoph Schwarz, Ulrika Asenbaum, Helmut Ringl, Fabian Fitschek, Klaus Kaczirek, Ahmed Ba-Ssalamah, Fredrik Waneck
Publikováno v:
European Radiology
To compare the value of functional future liver remnant (functFLR) to established clinical and imaging variables in prediction of post-hepatectomy liver failure (PHLF) after major liver resection. This retrospective, cross-sectional study included 62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68deb53ed6dda1e2beed4464ff12b547
http://europepmc.org/articles/PMC6182758
http://europepmc.org/articles/PMC6182758
Autor:
Fredrik Waneck, Claus Kölblinger, Sylvia Unterhumer, Dietmar Tamandl, Christian Loewe, Wolfgang Sieghart, Pascal A. T. Baltzer, Ahmed Ba-Ssalamah
Publikováno v:
European Journal of Radiology. 90:73-80
Purpose To determine the value of CT perfusion (CTP) for early response assessment after transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Materials and methods Between April 2013 and April 2015, 41 HCC (16 patients) were inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff33f5ae8a4b6f5fceeb0b7c750070bb
https://doi.org/10.1016/j.ejrad.2017.02.032
https://doi.org/10.1016/j.ejrad.2017.02.032
Autor:
Philipp B. Staber, Thorsten Fuereder, Gerald W. Prager, Fredrik Waneck, Markus Kieler, Stephan Polterauer, Matthias Unseld, Walter Berger, Matthias Preusser, Christoph C. Zielinski, Christine Marosi, Markus Raderer, Leonhard Müllauer, Daniela Bianconi, Robert M. Mader, Fritz Wrba, Maria Sibilia
Publikováno v:
ESMO Open
ESMO Open, Vol 4, Iss 4 (2019)
ESMO Open, Vol 4, Iss 4 (2019)
Background High-throughput genomic profiling of tumour specimens facilitates the identification of individual actionable mutations which could be used for individualised targeted therapy. This approach is becoming increasingly more common in the clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::788ef7c467f15def5c34e08596f38cf9
https://pubmed.ncbi.nlm.nih.gov/31423337
https://pubmed.ncbi.nlm.nih.gov/31423337